Related Experiment Video
Updated: Jul 11, 2026
11:13
Identification of Kinase-substrate Pairs Using High Throughput Screening
Published on: August 29, 2015
Dialogue between LKB1 and AMPK: a hot topic at the cellular pole
Christelle Forcet1, Marc Billaud
1CNRS Unité Mixte de Recherche 5201, Laboratoire de Génétique Moléculaire, Signalisation et Cancer, F-69008 Lyon, France.
Science'S STKE : Signal Transduction Knowledge Environment
|September 20, 2007
Summary
Liver kinase B1 (LKB1) acts as a tumor suppressor by linking energy sensing and cell polarity. This kinase signals through AMP-activated protein kinase (AMPK) to maintain epithelial cell structure, revealing a novel cancer checkpoint.
Area of Science:
- Cell biology
- Cancer research
- Metabolic signaling
Background:
- Malignant cells exhibit disrupted architecture and altered energy metabolism, known cancer hallmarks.
- The common signaling pathways linking these hallmarks were not well understood.
- Liver kinase B1 (LKB1) is a known tumor suppressor and upstream activator of AMP-activated protein kinase (AMPK), a cellular energy sensor.
Purpose of the Study:
- To investigate the role of LKB1 in connecting cell architecture and energy metabolism in cancer.
- To elucidate the signaling pathway involving LKB1 and AMPK in maintaining normal cell function.
Main Methods:
- Analysis of four independent studies investigating LKB1 signaling.
- Examination of LKB1's downstream effects on cellular structures and energy status.
Main Results:
- LKB1 signals through AMPK to promote the formation of tight junctions.
- LKB1 activation by AMPK is crucial for maintaining epithelial polarity.
- These findings establish a link between energy sensing and structural integrity.
Conclusions:
- LKB1 functions as a novel class of tumor suppressor.
- LKB1 acts as a critical checkpoint integrating cellular energy status and epithelial polarity.
- This pathway represents a potential target for cancer therapeutics.
Related Concept Videos
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
01:25cAMP-dependent Protein Kinase Pathways
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
01:19Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
01:22Amplifying Signals via Enzymatic Cascade
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
01:07MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
01:15Amplifying Signals via Second Messengers
Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...